NIST BMD Seminar: Next Gen COVID19 vaccines

IBBR Seminar Series

Nicole Tenly

Virtual

Deborah H. Fuller, PhD

Professor, Department of Microbiology, University of Washington School of Medicine; Division Chief, Infectious Diseases and Translational Medicine, Washington National Primate Research Center

Nucleic acid vaccines have emerged as the leading approach to combat the current COVID19 pandemic. However, there are still large regions in the world where vaccine distribution is sparse creating “vaccine deserts” where viral transmission and replication is occurring unchecked, increasing the likelihood of the emergence of a new variant of concern that could be resistant to current COVID19 vaccines. In addition, zoonotic transmission of a new betacoronavirus (CoV) remains a constant threat. The Fuller lab is developing next generation COVID19 DNA and RNA vaccine technologies that are stable at room temperature, can be self-administration and are capable of inducing long-lasting immunity not only against current circulating variants of concern but also, against the emergence of future variants and zoonotic outbreaks to prevent future pandemics.

 

Join Zoom Meeting
https://umd.zoom.us/j/91916745410?pwd=dmQvTlV0ZUQvU3JuVjVnRFhWZ1pGUT09

Meeting ID: 919 1674 5410
Passcode: 826708
One tap mobile
+13017158592,,91916745410# US (Washington DC)
+13126266799,,91916745410# US (Chicago)

Dial by your location
        +1 301 715 8592 US (Washington DC)
        +1 312 626 6799 US (Chicago)
        +1 929 436 2866 US (New York)
        +1 346 248 7799 US (Houston)
        +1 669 900 6833 US (San Jose)
        +1 253 215 8782 US (Tacoma)